LRRK2 and Parkinson disease: Importantly, this increase in acetyl-CoA appears to be consistent with the increased levels of acetylated proteins observed in patients with G2019S-LRRK2 mutation [47,48]; this phenotype was not observed in idiopathic PD patients.